glp-1 fda approved New Pill Foundayo (Orforglipron) Gets Approval for Obesity FDA Approves First Oral GLP-1

Interestingly, in SURPASS-4, the overall cohort of tirzepatide users and those with 30 mg/g UACR experienced an acute dip in eGFR at 12 weeks, resembling the eGFR slope observed in trials with semaglutide and other nephroprotective drugs, such as RAAS blockers [50] and SGLT-2i [51]

Many people start a GLP-1 medication expecting to feel better as the weight comes off

Epidemiological evidence has increasingly suggested that metformin, a commonly prescribed medication for type 2 diabetes, protects against the development of neurodegenerative diseases [23]

Insulin Secretion : GLP-1 drugs enhance insulin secretion in response to meals, improving blood sugar control and reducing the risk of diabetes, which is often associated with obesity

Regular physical activity helps regulate HPA axis function, though very high-intensity exercise without adequate recovery may temporarily increase cortisol levels in some individuals

Liu Z, Zhang M, Zhou T, Shen Q, Qin X